STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
STAT News · LC · trust 48/100
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
Read the original at STAT News →
Open in TruthVane →